Alzheimer’s

Double resignation over Aduhelm approval depletes FDA’s CNS adcomm

https://pharmaphorum.com/news/double-resignation-over-aduhelm-approval-depletes-fdas-cns-adcomm/

Biogen’s eye disease gene therapy fails ahead of FDA Alzheimer’s ruling

https://pharmaphorum.com/news/biogens-eye-disease-gene-therapy-fails-ahead-of-fda-alzheimers-ruling/

Health Innovators: Teresa Arroyo-Gallego, nQ Medical

https://pharmaphorum.com/video/health-innovators-teresa-arroyo-gallego-nq-medical/

Can your typing patterns reveal if you have Alzheimer’s?

https://pharmaphorum.com/views-and-analysis/can-your-typing-patterns-reveal-if-you-have-alzheimers/

2nd Gene Therapy for Neurological Disorders Europe

https://pharmaphorum.com/events/2nd-gene-therapy-for-neurological-disorders-europe/

FDA grew too close to Biogen during Alzheimer’s drug development, doctors say

https://pharmaphorum.com/news/fda-grew-too-close-to-biogen-during-alzheimers-drug-development-doctors-say/

Biogen shares soar as FDA delays decision on aducanumab

https://pharmaphorum.com/news/biogen-shares-soar-as-fda-delays-decision-on-aducanumab/

9th Annual Neurodegenerative Drug Development Summit

https://pharmaphorum.com/events/9th-annual-neurodegenerative-drug-development-summit/

Eisai forges CNS alliance with UK’s Wren Therapeutics

https://pharmaphorum.com/news/eisai-forges-cns-alliance-with-uks-wren-therapeutics/

1 2 3 4 5 >»

Close in 10 seconds

Pharmaphorum.com

Search